DEAL ANNOUNCEMENT | SALE OF SHARES FORMMED
DEAL ANNOUNCEMENT | OX8 CORPORATE FINANCE ACTS AS EXCLUSIVE ADVISOR TO THE SHAREHOLDER OF FORMMED HEALTHCARE AG ON THE INVESTMENT BY AVEDON CAPITAL PARTNERS Aschaffenburg / Frankfurt am Main / Düsseldorf, 29. July 2022 ox8 Corporate Finance exclusively advised the shareholder of FormMed HealthCare AG (“FormMed”) on the investment by Avedon Capital Partners (“Avedon”). FormMed […]
FormMed
ox8 Corporate Finance exclusively advised the shareholder of FormMed HealthCare AG (“FormMed”) on the investment by Avedon Capital Partners (“Avedon”). FormMed is a leading developer and supplier of micronutrients for therapeutic use. The founder Dr. Martin Lemperle will retain a significant stake in the company and will actively shape its further development. When founding FormMed […]